Can Fatty Liver Make You Throw Up?

Fatty liver disease can cause nausea and, in some cases, vomiting, particularly as the condition advances or during periods of poor diet. Fatty liver, known medically as hepatic steatosis, occurs when excess fat builds up within liver cells and encompasses both metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease. While many people have no symptoms at all, others experience upper abdominal discomfort, fatigue, and digestive upset. Understanding which symptoms are linked to fatty liver, when to seek medical advice, and how lifestyle changes can help is essential for protecting long-term liver health.

Can fatty liver disease actually cause nausea and vomiting?

Yes, fatty liver disease can cause nausea and sometimes vomiting, particularly when the liver is enlarged or inflammation is present, though these symptoms are non-specific and can arise from many other conditions.

Fatty liver disease may cause nausea, and in some people this extends to vomiting, particularly as the condition progresses or during periods of poor dietary intake. Fatty liver disease, known medically as hepatic steatosis, occurs when excess fat accumulates within liver cells. There are two main forms: metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease (NAFLD), and alcohol-related liver disease (ALD). Both can be associated with upper abdominal discomfort and nausea, though the precise mechanisms are not fully established.

Several factors are thought to contribute to nausea in fatty liver disease, though these remain incompletely understood. Where the liver is significantly enlarged (hepatomegaly), this may contribute to a sense of upper abdominal fullness or discomfort. In people who also have coexisting biliary disease or cholestasis, disrupted bile flow can contribute to nausea and intolerance of fatty foods; however, this is not a feature of simple steatosis alone. The NHS and British Liver Trust note that nausea and abdominal discomfort can occur as fatty liver disease progresses or when inflammation is present.^[1]

It is important to note that nausea and vomiting are not exclusive to fatty liver disease and can arise from many other conditions, including gastritis and gallstones. Gallstones may co-exist with fatty liver disease, as both share common metabolic risk factors.^[15][16] Vomiting blood or material that resembles coffee grounds is a medical emergency and requires immediate attendance at an accident and emergency department. For persistent but non-emergency nausea linked to a known or suspected liver condition, speaking to a GP is the appropriate first step.

What other symptoms does fatty liver cause alongside sickness?

Alongside nausea, fatty liver disease may cause fatigue, dull upper right abdominal pain, bloating, and loss of appetite; advanced disease can produce jaundice, ascites, and easy bruising.

In its early stages, fatty liver disease is often entirely silent, with many people unaware they have the condition until it is detected incidentally during an ultrasound or blood test. As fat accumulation increases or inflammation develops (a stage known as metabolic dysfunction-associated steatohepatitis, or MASH), some people begin to notice symptoms, though these remain non-specific.

Symptoms that may be associated with fatty liver disease include:

• Fatigue and low energy, which can be persistent and disproportionate to activity levels

• Dull or aching pain in the upper right abdomen, which may occur when the liver is enlarged (hepatomegaly)

• Bloating and indigestion, particularly after fatty or rich meals

• Loss of appetite, which may contribute to unintentional weight loss in more advanced cases

Cognitive symptoms such as difficulty concentrating are not a recognised feature of early or uncomplicated fatty liver disease. Significant cognitive effects, including confusion, are associated with advanced liver disease and hepatic encephalopathy, which occurs in the context of cirrhosis.^[6][13]

If fatty liver progresses to cirrhosis (scarring of the liver), more serious symptoms can develop. These include jaundice (yellowing of the skin and whites of the eyes), swelling of the abdomen due to fluid accumulation (ascites), swollen ankles and legs, and easy bruising or bleeding. Spider-like blood vessels visible on the skin (spider naevi) and redness of the palms (palmar erythema) may also appear.

The severity of symptoms does not always reflect the degree of liver damage. Some people with significant fibrosis or early cirrhosis may still feel relatively well, which is why regular monitoring through a GP or liver specialist is important for anyone with a confirmed diagnosis.

When should you see a GP about nausea and liver problems?

See a GP if nausea persists for more than a few days with upper abdominal pain, unexplained weight loss, or jaundice; call 999 or go to A&E immediately if you vomit blood or develop sudden confusion.

You should see a GP if nausea persists for more than a few days without a clear cause, particularly if it is accompanied by upper abdominal pain, unexplained weight loss, or any yellowing of the skin or eyes. These combinations of symptoms may indicate that the liver is under significant stress and warrant prompt clinical assessment. NICE guidance NG49 (Non-alcoholic fatty liver disease: assessment and management) recommends that people with risk factors such as obesity, type 2 diabetes, or metabolic syndrome are assessed for liver disease; a GP can arrange appropriate blood tests and imaging.^[3][4] Note that while NICE NG49 uses the term NAFLD, this condition is now more commonly referred to as MASLD in current clinical practice.

Certain symptoms require more urgent attention. Contact NHS 111 if you develop sudden, severe abdominal pain that does not settle, or if you are vomiting repeatedly and cannot keep fluids down. Call 999 or go directly to an accident and emergency department if you vomit blood, pass very dark or tarry stools, or experience sudden confusion alongside liver symptoms, as these may indicate serious complications such as gastrointestinal bleeding or hepatic encephalopathy.

Investigations a GP may arrange include liver function tests (LFTs), a full blood count, fasting glucose and lipid profile, and an abdominal ultrasound. Where LFTs are abnormal, UK guidance also recommends tests to exclude other causes of liver disease, which may include hepatitis B and C serology, autoimmune liver screen, ferritin and transferrin saturation (to screen for haemochromatosis), and coeliac serology where clinically indicated.^[3][5]

NICE NG49 and BSG guidance support the use of non-invasive fibrosis risk stratification in primary care. A FIB-4 score or NAFLD Fibrosis Score (NFS) can be calculated from routine blood results to estimate the likelihood of significant fibrosis. Where the result is indeterminate or suggests higher risk, second-line assessment with an enhanced liver fibrosis (ELF) test or transient elastography (FibroScan) may be arranged. Referral to hepatology is recommended where advanced fibrosis is suspected. Early identification of fatty liver disease allows for timely lifestyle intervention before significant fibrosis develops.

For those seeking an initial assessment or ongoing management of a suspected liver condition, a GP referral to a hepatologist or gastroenterologist may be appropriate depending on the clinical picture. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, which may be a useful starting point for people seeking guidance on metabolic health.

What lifestyle changes can help ease fatty liver symptoms?

Gradual weight loss of 7 to 10 per cent of body weight, a Mediterranean-style diet, and at least 150 minutes of moderate exercise per week are the most effective evidence-based interventions for MASLD.

Gradual, sustained weight loss through dietary change and increased physical activity is the most effective lifestyle intervention for reducing fat in the liver and easing associated symptoms such as nausea and fatigue. NICE NG49 supports a target weight loss of 7 to 10 per cent of body weight in people with MASLD, as this level of reduction has been shown to meaningfully reduce liver fat and inflammation.^[3][5] Weight loss should be gradual rather than rapid: very low-calorie crash diets are not recommended, as rapid weight loss may temporarily worsen liver inflammation and can increase the risk of gallstone formation.

Dietary changes that support liver health include:

• Reducing intake of ultra-processed foods, refined carbohydrates, and added sugars, particularly fructose found in sugary drinks

• Limiting or avoiding alcohol, which places direct toxic stress on liver cells regardless of the underlying cause of fatty liver

• Increasing consumption of vegetables, wholegrains, legumes, and oily fish, in line with a Mediterranean-style dietary pattern, which has evidence supporting its benefit in MASLD per EASL clinical practice guidelines^[17]

• Eating smaller, more frequent meals to reduce the digestive burden and ease nausea, particularly avoiding large fatty meals

Regular physical activity is equally important. Both aerobic exercise (such as brisk walking, cycling or swimming) and resistance training have been shown to reduce liver fat, including independently of weight loss.^[18][19] UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, and this target is supported by NICE NG49 for people with MASLD.^[9][10]

Avoiding hepatotoxic substances is also essential. Some over-the-counter medications and herbal supplements can place additional strain on a compromised liver. Paracetamol should not be taken above the recommended dose stated on the packaging; in people with significant liver disease, the appropriate dose may differ and should be discussed with a pharmacist or GP before use. The British Liver Trust provides further guidance on medicines and liver health. People with fatty liver disease should not stop prescribed medications without first consulting their GP.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD).
2. Cirrhosis.
3. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
4. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) — recommendations for research.
5. Non-Alcoholic Fatty Liver Disease: Assessment and Management (NG49).
6. Hepatic encephalopathy — maintenance treatment with rifaximin: final scope (TA337).
7. MRI-based technologies for assessing non-alcoholic fatty liver disease — the diagnostic tests (HTG655).
8. HTG655 final scope — non-alcoholic fatty liver disease assessment technologies.
9. Physical activity guidelines: UK Chief Medical Officers' report.
10. Physical activity guidelines for adults aged 19 to 64.
11. AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction- and Alcohol-Associated Liver Disease: Expert Review.
12. Global epidemiological patterns and disease burden of MASLD, MetALD, and ALD.
13. Covert hepatic encephalopathy in cirrhosis: implications for early diagnosis and appropriate management.
14. Glymphatic Dysfunction in Hepatic Encephalopathy: A Novel Pathogenetic Pathway and Potential Target for New Therapeutic Opportunities.
15. Prevalence and metabolic correlates of gallbladder stones among community-dwelling older adults in Chongqing, China.
16. Body mass index as a predictor of MASLD — insights from the Polish Gallstone Surgery Registry.
17. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
18. Structured Exercise Interventions and Hepatic-Metabolic Outcomes in Adults with MASLD: A Narrative Review of Randomized Controlled Trials.
19. Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease.

Frequently Asked Questions